Randomised, clinical trial, controlled, open-label, multicenter, non-profit study to evaluate the superiority of a complementary treatment with additional Homeopathic Medicines and Acupuncture / Auriculotherapy compared to an active control group with only Cognitive Rehabilitation and Nutritional Advice. - CHEMOCIM

AZIENDA USL TOSCANA NORD OVEST0 个研究点目标入组 320 人开始时间: 2021年2月10日最近更新: 2021年8月30日

适应症

试验速览

暂无简介。

•Aged between 18 and 65;
•Breast cancer diagnosis (stage: I-III A) within 12 months of enrollment;
•Standard dose adjuvant chemotherapy for at least 3-6 months and concluded for at least 2 months and / or endocrine therapy in progress for at least 6 months;
•Signature of Informed Consent.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 320
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Known metastatic tumor;
•History of previous severe neurological or psychiatric disorders (Epilepsy, MCI, Dementia, Psychosis, etc.);
•Positive history of oncological pathology within 5 years from the date of enrollment;
•Family history of past neurological or psychiatric disorders;
•Concomitant therapies with psychoactive drugs;
•Severe needle phobia.

发起方

AZIENDA USL TOSCANA NORD OVEST